Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 26, 2017
Risks associated with antiretroviral treatment for human immunodeficiency virus (HIV): qualitative analysis of social media data and health state utility valuationLouis S Matza, Karen C Chung, Katherine J Kim, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 29, 2013
Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adultsPeter J Ruane, Edwin DeJesus, Daniel Berger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2016
A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected AdultsGregory D Huhn, Pablo Tebas, Joel Gallant, et al.
Journal of the International AIDS Society|November 15, 2014
Phase IIIb, open-label single-arm trial of darunavir/cobicistat (DRV/COBI): Week 48 subgroup analysis of HIV-1-infected treatment-nave adultsKaren Tashima, Gordon Crofoot, Frank L Tomaka, et al.
AIDS Research and Therapy|May 1, 2015
Cobicistat-boosted darunavir in HIV-1-infected adults: week 48 results of a Phase IIIb, open-label single-arm trialKaren Tashima, Gordon Crofoot, Frank L Tomaka, et al.
Archives of Physical Medicine and Rehabilitation|September 1, 1975
Stroke: Does rehabilitation affect outcome?J F Lehmann, B J DeLateur, R S Fowler, et al.
American Journal of Medical Genetics|January 1, 1981
A comprehensive scoring system for evaluating Noonan syndromeW J Duncan, R S Fowler, L G Farkas, et al.
Archives of Physical Medicine and Rehabilitation|September 1, 1975
Stroke rehabilitation: Outcome and predictionJ F Lehmann, B J DeLateur, R S Fowler, et al.
Pageof 5